These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 6331340

  • 1. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M, Myc A, Matej H, Rudzka L.
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
    [Abstract] [Full Text] [Related]

  • 2. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
    Wasik M, Matej H, Duś D, Myc A.
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):879-85. PubMed ID: 6331341
    [Abstract] [Full Text] [Related]

  • 3. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G, Straus S, Henle W, Pike SE, Blaese RM.
    J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
    [Abstract] [Full Text] [Related]

  • 4. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
    Strang G, Rickinson AB.
    Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228
    [Abstract] [Full Text] [Related]

  • 5. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E, Ernberg I, Masucci MG, Szigeti R, Wu YT, Masucci G, Svedmyr E.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [Abstract] [Full Text] [Related]

  • 6. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
    Thorley-Lawson DA.
    J Immunol; 1980 Feb; 124(2):745-51. PubMed ID: 6243331
    [Abstract] [Full Text] [Related]

  • 7. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
    Sairenji T, Nguyen QV, Woda B, Humphreys RE.
    J Immunol; 1987 Apr 15; 138(8):2645-52. PubMed ID: 2435803
    [Abstract] [Full Text] [Related]

  • 8. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
    Royston I, Sullivan JL, Periman PO, Perlin E.
    N Engl J Med; 1975 Dec 04; 293(23):1159-63. PubMed ID: 171568
    [Abstract] [Full Text] [Related]

  • 9. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
    Al Tabaa Y, Tuaillon E, Jeziorski E, Ouedraogo DE, Bolloré K, Rubbo PA, Foulongne V, Rodière M, Vendrell JP.
    J Clin Virol; 2011 Sep 04; 52(1):33-7. PubMed ID: 21684200
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus-specific cytoskeletal early antigen in EBV-transformed cell lines.
    Sairenji T, Nguyen QV, Woda B, Humphreys RE.
    AIDS Res; 1986 Dec 04; 2 Suppl 1():S57-60. PubMed ID: 3030348
    [Abstract] [Full Text] [Related]

  • 11. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.
    Tosato G, Magrath I, Koski I, Dooley N, Blaese M.
    N Engl J Med; 1979 Nov 22; 301(21):1133-7. PubMed ID: 226884
    [Abstract] [Full Text] [Related]

  • 12. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M.
    Clin Exp Immunol; 1976 Jul 22; 25(1):1-5. PubMed ID: 186222
    [Abstract] [Full Text] [Related]

  • 13. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ, McAulay KA, Anthony IC, Crawford DH.
    J Med Virol; 2009 May 22; 81(5):870-7. PubMed ID: 19319950
    [Abstract] [Full Text] [Related]

  • 14. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters.
    Nikoskelainen J, Ablashi DV, Isenberg RA, Neel EU, Miller RG, Stevens DA.
    J Immunol; 1978 Oct 22; 121(4):1239-44. PubMed ID: 81224
    [Abstract] [Full Text] [Related]

  • 15. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R, Frisan T, Sjöberg J, De Campos-Lima PO, Pisa P, De Re V, Gloghini A, Rizzo S, Masucci MG, Boiocchi M.
    Cancer Res; 1995 Aug 15; 55(16):3675-81. PubMed ID: 7627978
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients.
    Rickinson AB, Crawford D, Epstein MA.
    Clin Exp Immunol; 1977 Apr 15; 28(1):72-9. PubMed ID: 193663
    [Abstract] [Full Text] [Related]

  • 17. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N, Kimura H, Hara S, Hoshino Y, Kojima S, Morishima T, Tsurumi T, Kuzushima K.
    J Infect Dis; 2004 Sep 01; 190(5):985-8. PubMed ID: 15295706
    [Abstract] [Full Text] [Related]

  • 18. Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV).
    Gergely P, Ernberg I, Klein G, Steinitz M.
    Clin Exp Immunol; 1977 Dec 01; 30(3):347-53. PubMed ID: 203426
    [Abstract] [Full Text] [Related]

  • 19. B cells under influence: transformation of B cells by Epstein-Barr virus.
    Küppers R.
    Nat Rev Immunol; 2003 Oct 01; 3(10):801-12. PubMed ID: 14523386
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
    Akiyama N, Ohsawa N, Kusaba R, Inou T, Takada M.
    Jpn J Exp Med; 1981 Feb 01; 51(1):1-7. PubMed ID: 6273617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.